Gracell Biotechnologies Inc. Quarterly Liabilities and Equity in CNY from Q4 2019 to Q2 2023

Taxonomy & unit: us-gaap: CNY and USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Gracell Biotechnologies Inc. quarterly Liabilities and Equity history and growth rate from Q4 2019 to Q2 2023.
Gracell Biotechnologies Inc. Liabilities and Equity for the quarter ending June 30, 2023 was ¥1.38B, a 27.4% decline year-over-year.

Liabilities and Equity, Quarterly (CNY)

Liabilities and Equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	1.38B	-521M	-27.4%	Jun 30, 2023	6-K	2023-08-14
Q4 2022	1.66B	-404M	-19.6%	Dec 31, 2022	6-K	2023-08-14
Q2 2022	1.9B			Jun 30, 2022	6-K	2022-08-15
Q4 2021	2.06B	+1.1B	+113%	Dec 31, 2021	20-F	2023-04-25
Q4 2020	965M	+553M	+134%	Dec 31, 2020	20-F	2022-04-22
Q4 2019	412M			Dec 31, 2019	20-F	2021-04-23

* An asterisk sign (*) next to the value indicates that the value is likely invalid.